![Patrick Heron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Heron
Director/Board Member at
ARCUTIS BIOTHERAPEUTICS, INC.
Net worth: 2 M $ as of 30/05/2026
Profile
Mr. Patrick J.
Heron is a Lead Independent Director at MBX Biosciences, Inc., an Independent Director at Mirum Pharmaceuticals, Inc., an Independent Director at Arcutis Biotherapeutics, Inc. and a Managing Partner at Frazier Management LLC.
He is on the Board of Directors at MBX Biosciences, Inc., Mirum Pharmaceuticals, Inc., Arcutis Biotherapeutics, Inc., Alpha-9 Oncology, Inc., Bluewater Biosciences, Inc., Iterum Therapeutics International Ltd., Iterum Therapeutics US Holding Ltd., VentiRx Pharmaceuticals, Inc., Zavante Therapeutics, Inc. and Calibrium LLC.
Mr. Heron was previously employed as an Independent Director by HilleVax, Inc., an Independent Non-Executive Director by Passage Bio, Inc., a Chairman by Scout Bio, Inc., an Independent Director by Vaxcyte, Inc., an Independent Director by Iterum Therapeutics Plc, an Independent Director by Tobira Therapeutics, Inc., an Independent Director by Imago BioSciences, Inc., an Independent Director by Cidara Therapeutics, Inc., an Independent Director by Collegium Pharmaceutical, Inc., an Independent Director by Tobira Therapeutics, Inc. /Old/, an Engagement Manager by McKinsey & Co., Inc., a Principal by Cetus Corp., a Chairman by Kalidex Pharmaceuticals, Inc., and a Principal by The General Hospital Corp.
He also served on the board at SanReno Therapeutics, Silvergate Pharmaceuticals, Inc., Calixa Therapeutics, Inc., Marcadia Biotech, Inc., Cerexa, Inc., Trubion Pharmaceuticals, Inc., MedPointe, Inc., QuatRx Pharmaceuticals Co., Amunix, Inc., ARMO Biosciences, Inc., Avera Pharmaceuticals, Inc., Chimerix, Inc., Ignyta, Inc., Informed Medical Communications, Inc., Moximed, Inc., Panomics LLC, PreCision Dermatology, Inc. and Recida Therapeutics, Inc. He received his undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2026 | 32,213 ( 0.03% ) | 691 291 $ | 30/05/2026 | |
| 14/06/2026 | 5,703 ( 0.01% ) | 578 855 $ | 30/05/2026 | |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company 0.03% | 30/01/2025 | 9,110 ( 0.03% ) | 507 154 $ | 30/05/2026 |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders 0.02% | 31/10/2025 | 14,937 ( 0.02% ) | 143 246 $ | 30/05/2026 |
| 03/06/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Patrick Heron active positions
| Companies | Position | Start |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | - |
| MIRUM PHARMACEUTICALS, INC. | Director/Board Member | 06/11/2018 |
| MBX BIOSCIENCES, INC. | Director/Board Member | 30/06/2020 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 31/07/1999 |
Calibrium LLC
 Calibrium LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals and diabetic drugs | Director/Board Member | - |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Director/Board Member | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Director/Board Member | - |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | - |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Director/Board Member | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Patrick Heron
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Patrick Heron
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
45
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 45 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutic compounds | Health Technology |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences research reagents | Commercial Services |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops drugs and therapies | Health Services |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Informed Medical Communications, Inc.
 Informed Medical Communications, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical forums, training services, and integrated medical communications | Commercial Services |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines | Health Technology |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for diabetes and obesity | Health Technology |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hospital-based anti-infective therapies | Health Technology |
Kalidex Pharmaceuticals, Inc.
 Kalidex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops antibiotics for the treatment of serious infections | Health Technology |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
Silvergate Pharmaceuticals, Inc.
 Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Calibrium LLC
Calibrium LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals and diabetic drugs | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets, and sells therapeutics | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Develops protein pharmaceuticals | Health Technology |
Moximed, Inc.
 Moximed, Inc. Medical SpecialtiesHealth Technology Develops medical device treatments | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that specializes in veterinary, animal health and gene therapy | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development of novel therapeutics | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
HilleVax, Inc.
 HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
Sanreno Therapeutics
 Sanreno Therapeutics BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the discovery, development and commercialization of therapies for kidney diseases | Health Technology |
Bluewater Biosciences, Inc.
 Bluewater Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel platform for unimolecular multi-target medicines | Commercial Services |
- Stock Market
- Insiders
- Patrick Heron
